BIO InvestorForum 2005 Spotlights Biotech Companies Poised for Growth

Media Registration Now Open for Oct. 18-20 San Francisco Conference

WASHINGTON, Sept. 8 Media registration is now open for BIO
InvestorForum 2005, Oct. 18-20 in San Francisco at The Palace Hotel.
Organized by the Biotechnology Industry Organization (BIO), BIO
InvestorForum 2005 will focus on the biotechnology companies,
clinical development areas and research programs that are considered
to be investor growth areas.

"This conference is the best opportunity this fall for biotechnology
journalists to meet industry leaders, including CEOs, clinical
investigators and financial experts, and discover the trends that
will shape the biotechnology industry in the coming year," said
Morrie Ruffin, BIO's Executive Vice President, Capital Formation
Section and Business Development.

The BIO InvestorForum 2005 will feature select company
presentations, dynamic panel discussions and keynote speeches on
such topics as clinical strategy, product development and the
shifting regulatory landscape. Discussion will center on growth
potential for both public and private companies, as well as the
areas most likely to be considered for the "growth watch list" in
2006. In attendance will be institutional investors, venture and
private equity investors, as well as research analysts and bankers
representing leading banks in the sector.

A series of Therapeutic Workshops and CEO Roundtables will explore
hot topics and debate the growth challenges facing the industry.
Therapeutic topics include:

- Developing New Pain Therapeutics in the Post-Vioxx World
- Clinical Development and Regulatory Trends in the Era of
Targeted
Cancer Therapies
- Cancer Genome Sequencing Project, Part 1: Implications for
Sequencing
Technology
- Sleeping Giant: Opportunities in Sleep Disorders
- New Strategies and New Hope in Lupus
- Cardiovascular Disease: Not for the Faint-Hearted

The slate of CEO Roundtable sessions was developed based on popular
demand and includes:

- Tales from the Trenches: Getting Through an IPO and Thriving
in the
Aftermarket
- Demystifying Hedge Funds
- Increasing Valuation Through Milestone-Driven Development
Strategy and

Strategic Outsourcing
- New Fundraising Strategies and Case Studies in the Current
Public
Financing Environment
- The Last Word on the Watch List for 2006: The Buyside Versus
Investigator View of Events that Will Shape 2006

Full conference details and online registration are available at
http://www.bio.org/. The hosts of the BIO InvestorForum 2005 are
Bank of America and Lehman Brothers. Co-hosts are CIBC World
Markets, Jefferies, and RBC Capital Markets. Supporting Partners are
BayBio, BIOCOM and BIOTECanada.

About BIO

BIO represents more than 1,100 biotechnology companies, academic
institutions, state biotechnology centers and related organizations
across the United States and in 31 other nations. BIO members are
involved in the research and development of healthcare,
agricultural, industrial and environmental biotechnology products.

Source: Biotechnology Industry Organization

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech